lobbying_activities: 2591941

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2591941	ac2380e7-1063-405c-9e7f-5849ab870d71	Q1	ADVANCED POLICY CONSULTING, LLC	401103524	AMGEN USA INC.	2021	first_quarter	HCR	Monitoring healthcare legislation. Education regarding market based solutions to bring down the cost of drug prices. Education regarding the dangers of global counterfeit medications. Education regard the International Pricing Index (IPI) Model, which would import single-payer government run price controls that limit innovation and patient access to life saving therapies. Support rebate rule to bring down the cost of drug prices. Education regarding the bio-similars market place. Support the increased access to Osteoporosis testing for Medicare. Monitor COVID-19 legislation.	Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE	30000		0	0	2021-04-05T11:16:45.997000-04:00